Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Relevance AI
start up
Australia
- Sydney, New South Wales
- 15/12/2023
- Series A
- $15,000,000
At Relevance AI, our mission is to be the home of the AI workforce. Our no-code platform enables anyone to build AI teams, equipped with custom AI tools.
- Industry Software Development
- Website https://relevanceai.com/
- LinkedIn https://www.linkedin.com/company/relevanceai/about/
Related People
Daniel VassilevCo Founder
United States -
San Francisco, California
Relevance AI is a low-code platform for building AI tools and agents.
Developer and data. Previously created, grew and monetised two apps to a combined 7 million users, reaching #1 on the App Store top free. Trying to perfect building, growing and monetising products over five years.
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)